前往化源商城

(-)-MDO-NPA HCl

更新时间:2024-01-09 22:15:50

(-)-MDO-NPA HCl结构式
(-)-MDO-NPA HCl结构式
品牌特惠专场
常用名 (-)-MDO-NPA HCl 英文名 (-)-MDO-NPA HCl
CAS号 81264-57-5 分子量 307.38600
密度 1.209g/cm3 沸点 456ºC at 760 mmHg
分子式 C20H21NO2 熔点 250-252ºC
MSDS 美版 闪点 165.2ºC

 (-)-MDO-NPA HCl用途


(-)-MDO-NPA HCl is an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines.

 (-)-MDO-NPA HCl名称

英文名 (6aR)-7-Propyl-6a,7,8,9-tetrahydro-6H-benzo[de][1,3]benzodioxolo[ 4,5-g]quinoline
英文别名 更多

 (-)-MDO-NPA HCl物理化学性质

密度 1.209g/cm3
沸点 456ºC at 760 mmHg
熔点 250-252ºC
分子式 C20H21NO2
分子量 307.38600
闪点 165.2ºC
精确质量 307.15700
PSA 21.70000
LogP 3.88550
折射率 1.622

 (-)-MDO-NPA HCl安全信息

个人防护装备 Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
危险品运输编码 NONH for all modes of transport
WGK德国 3

 (-)-MDO-NPA HCl合成线路

~92%

(-)-MDO-NPA HCl结构式

(-)-MDO-NPA HCl

81264-57-5

文献:Ram, Vishnu J.; Neumeyer, John L. Journal of Organic Chemistry, 1981 , vol. 46, # 13 p. 2830 - 2831

~%

(-)-MDO-NPA HCl结构式

(-)-MDO-NPA HCl

81264-57-5

文献:Ram, Vishnu J.; Neumeyer, John L. Journal of Organic Chemistry, 1981 , vol. 46, # 13 p. 2830 - 2831

~%

(-)-MDO-NPA HCl结构式

(-)-MDO-NPA HCl

81264-57-5

文献:Ram, Vishnu J.; Neumeyer, John L. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1988 , vol. 27, # 1-12 p. 947 - 949

~%

(-)-MDO-NPA HCl结构式

(-)-MDO-NPA HCl

81264-57-5

文献:Ram, Vishnu J.; Neumeyer, John L. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1988 , vol. 27, # 1-12 p. 947 - 949

~%

(-)-MDO-NPA HCl结构式

(-)-MDO-NPA HCl

81264-57-5

文献:Ram, Vishnu J.; Neumeyer, John L. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1988 , vol. 27, # 1-12 p. 947 - 949

~%

(-)-MDO-NPA HCl结构式

(-)-MDO-NPA HCl

81264-57-5

文献:Ram, Vishnu J.; Neumeyer, John L. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1988 , vol. 27, # 1-12 p. 947 - 949

 (-)-MDO-NPA HCl文献8

更多文献
Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines.

Neuropharmacology 21(10) , 953-61, (1982)

Substituted and unsubstituted 10,11-methylenedioxy derivatives of apomorphine (APO) or its N-propyl congener (NPA) were synthesized and evaluated for their ability to alter motor activity or to induce...

Dopaminergic stimulation of oxytocin concentrations in the plasma of male and female monkeys by apomorphine and a D2 receptor agonist.

J. Clin. Endocrinol. Metab. 75(3) , 855-60, (1992)

Administration of the dopamine receptor agonist apomorphine causes a dose-dependent increase in plasma oxytocin concentrations and dose-specific behavioral changes in rodents. To investigate whether d...

Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors.

Neuropharmacology 21(12) , 1311-6, (1982)

High performance liquid chromatography with electrochemical detection was used to assay N-n-propylnorapomorphine (NPA) and other aporphines. Pretreatment of rats with (-)10,11-methylenedioxy-N-n-propy...

 (-)-MDO-NPA HCl英文别名

(R)-MDO-NPA
(S)-Propane-1,2-diamine dihydrochloride
R-(-)-1,2-propanediamine dihydrochloride
(S)-1,2-diaminopropane
(S)-diaminopropane dihydrochloride
R(-)-10,11-Methylenedioxy-N-(n-propyl)noraporphine
(S)-1,2-propanediamine*2HCl
(S)-1,2-Diaminopropane 2HCl
S-(-)-1,2-diaminopropane dihydrochloride
(S)-1,2-Propanediamine dihydrochloride